You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 5, May 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The stability of perfluoro-N-octane during vitreoretinal procedures

R. D. Bourke, R. N. Simpson, R. J. Cooling and J. R. Sparrow
Moorfields Eye Hospital, London, England.

OBJECTIVES: To examine the propensity for intraoperative procedures, such as endolaser, to generate polar impurities in perfluorocarbon liquids, either by degradation of the compound or by dissolution of materials contacting the liquid, given the value of these liquids as adjuncts to vitreoretinal procedures and the importance of using pure and inert liquid. METHODS: Perfluoro-N-octane liquid recovered from patients after vitreoretinal procedures was analyzed by gas chromatography, nuclear magnetic resonance, ultraviolet spectroscopy, and a cell proliferation assay. Similar analyses were performed on pure and impure perfluoro-N-octane exposed in vitro to superclinical energy levels of argon and YAG laser, endodiathermy, and endoillumination. RESULTS: No change in chemical structure and only minor (parts per million) increases in dissolved contaminants were observed. The perfluoro-N-octane liquid retained its inertness as indicated by the inability of fibroblasts to attach and proliferate on its surface. CONCLUSION: The structure and biologic inactivity of perfluoro-N-octane are unaffected by vitreoretinal surgical manipulations.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Displacement of Retained Subfoveal Perfluorocarbon Liquid After Vitreoretinal Surgery
Le Tien et al.
Arch Ophthalmol 2008;126:98-101.
ABSTRACT | FULL TEXT  

CT Characteristics of Intraocular Perfluoro-N-Octane
Christoforidis et al.
Am. J. Neuroradiol. 2003;24:1769-1771.
ABSTRACT | FULL TEXT  

Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy
Imamura et al.
Br. J. Ophthalmol. 2003;87:563-566.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.